Amelioration of IFN-γ and TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Berberine via Suppression of MLCK-MLC Phosphorylation Signaling Pathway
Open Access
- 3 May 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (5), e61944
- https://doi.org/10.1371/journal.pone.0061944
Abstract
Intestinal barrier dysfunction occurs in many intestinal diseases, in which proinflammatory cytokines play critical roles. However, researchers are still on the way to defining the underlying mechanisms and to evaluate therapeutic strategies for restoring intestinal barrier function. Berberine, a drug that has clinically been used to treat gastroenteritis and diarrhea for thousands of years, has been shown to protect barrier function in both endothelial and epithelial cells, but the mechanisms are completely unknown. In this study, we investigate the protective actions of berberine on barrier function and the underlying mechanisms in Caco-2 monolayers challenged with IFN-γ and TNF-α. Caco-2 monolayers were treated without or with simultaneous IFN-γ and TNF-α in the absence or presence of berberine. Both transepithelial electrical resistance (TER) and paracellular permeability were measured to evaluate barrier function. The expression and distribution of tight junction proteins ZO-1, occluding, and claudin-1 were respectively analyzed by immunoblot or immunofluorescence. The expressions of phosphorylated myosin light chain (pMLC), MLC kinase (MLCK) and hypoxia-inducible factor-1α (HIF-1α) were determined by immunoblot. The translocation of NF-κB p65 to nuclei was analyzed by immunofluorescence and immunoblot, respectively. The results showed that berberine significantly attenuated TER decrease and paracellular permeability increase in Caco-2 monolayers treated with IFN-γ and TNF-α. Berberine also dramatically alleviated IFN-γ and TNF-α-induced morphological alteration of tight junction proteins ZO-1, occluding, and claudin-1. The increase of both MLC phosphorylation and MLCK protein expression induced by IFN-γ and TNF-α was significantly inhibited by berberine treatment. Additionally, berberine suppressed the activation of HIF-1α, but not NF-κB. Taken together, it is suggested that berberine attenuates IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by inhibiting the signaling pathway of MLCK-dependent MLC phosphorylation mediated by HIF-1α.Keywords
This publication has 56 references indexed in Scilit:
- Berberine Induces Caspase-Independent Cell Death in Colon Tumor Cells through Activation of Apoptosis-Inducing FactorPLOS ONE, 2012
- STAT6 activation in ulcerative colitis: A new target for prevention of IL-13-induced colon epithelial cell dysfunctionInflammatory Bowel Diseases, 2011
- HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cellsCellular and Molecular Life Sciences, 2011
- Involvement of HIF-1α in MLCK-dependent Endothelial Barrier Dysfunction in HypoxiaCellular Physiology and Biochemistry, 2011
- TNFα-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFκB signalingJournal of Cell Science, 2010
- The effect of berberine in vitro on tight junctions in human Caco-2 intestinal epithelial cellsFitoterapia, 2009
- Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gammain vitro: A novel model for studying the pathomechanisms of inflammatory bowel disease cytokinesScandinavian Journal of Gastroenterology, 2009
- Mechanism of IL-1β-Induced Increase in Intestinal Epithelial Tight Junction PermeabilityThe Journal of Immunology, 2008
- The anti-inflammatory potential of berberine in vitro and in vivoCancer Letters, 2003
- Cytokines induce HIF-1 DNA binding and the expression of HIF-1-dependent genes in cultured rat enterocytesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2003